• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于某些系列抗乙型肝炎病毒(HBV)药物的定量构效关系(QSAR)研究。

A QSAR study on some series of anti-hepatitis B virus (HBV) agents.

作者信息

Arora Preet K, Patil Vaishali M, Gupta Satya P

机构信息

Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut 250005, India.

出版信息

Bioinformation. 2010 Mar 31;4(9):417-20. doi: 10.6026/97320630004417.

DOI:10.6026/97320630004417
PMID:20975892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2951641/
Abstract

A quantitative structure-activity relationship (QSAR) study has been made on some series of anti-hepatitis B virus (HBV) agents, namely, a series of novel bis(L-amino acid) ester prodrugs of 9-[2--(phosphonomethoxy)ethyl]adenine, a similar series of compounds comprising of 2- amino-6-arylthio-9-[2-(phosphonoethoxy)ethyl] purine bis(2,2,2- trifluoroethyl) esters, and a series of 1-isopropylsulfonyl-2-amine benzimidazoles. In each case significant correlations are found between the anti-HBV potencies and some physicochemical and steric properties of the compounds, indicating that for the first two series the activity is controlled by the hydrophobic and the bulk properties of the molecules and, for the third series, the steric and hydrogen bonding properties of compounds are crucial for their anti-HBV potency.

摘要

已对一些系列的抗乙型肝炎病毒(HBV)药物进行了定量构效关系(QSAR)研究,这些药物包括:一系列新型的9-[2-(膦酰甲氧基)乙基]腺嘌呤双(L-氨基酸)酯前药、一系列由2-氨基-6-芳硫基-9-[2-(膦酰乙氧基)乙基]嘌呤双(2,2,2-三氟乙基)酯组成的类似化合物系列,以及一系列1-异丙基磺酰基-2-胺苯并咪唑。在每种情况下,均发现化合物的抗HBV效力与某些物理化学和空间性质之间存在显著相关性,这表明对于前两个系列,活性受分子的疏水性和体积性质控制,而对于第三个系列,化合物的空间和氢键性质对其抗HBV效力至关重要。

相似文献

1
A QSAR study on some series of anti-hepatitis B virus (HBV) agents.关于某些系列抗乙型肝炎病毒(HBV)药物的定量构效关系(QSAR)研究。
Bioinformation. 2010 Mar 31;4(9):417-20. doi: 10.6026/97320630004417.
2
2-Amino-6-arylthio-9-[2-(phosphonomethoxy)ethyl]purine bis(2,2,2-trifluoroethyl) esters as novel HBV-specific antiviral reagents.2-氨基-6-芳硫基-9-[2-(膦酰甲氧基)乙基]嘌呤双(2,2,2-三氟乙基)酯作为新型乙肝病毒特异性抗病毒试剂。
J Med Chem. 2002 Jul 4;45(14):3138-42. doi: 10.1021/jm020036x.
3
Synthesis of 2-amino-6-(4-[11C]methoxyphenylthio)-9-[2-(phosphonomethoxy)ethyl]purine bis(2,2,2-trifluoroethyl) ester as a novel potential PET gene reporter probe for HBV and HSV-tk in cancers.2-氨基-6-(4-[¹¹C]甲氧基苯硫基)-9-[2-(膦酰基甲氧基)乙基]嘌呤双(2,2,2-三氟乙基)酯的合成作为一种用于癌症中乙肝病毒和单纯疱疹病毒胸苷激酶的新型潜在正电子发射断层显像基因报告探针。
Bioorg Med Chem. 2005 Jan 17;13(2):549-56. doi: 10.1016/j.bmc.2004.10.007.
4
Design and synthesis of novel bis(L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with improved anti-HBV activity.9-[2-(膦酰甲氧基)乙基]腺嘌呤(PMEA)新型双(L-氨基酸)酯前药的设计与合成及其抗乙肝病毒活性的提高
Bioorg Med Chem Lett. 2007 Jan 15;17(2):465-70. doi: 10.1016/j.bmcl.2006.10.021. Epub 2006 Oct 12.
5
Identification of 1-isopropylsulfonyl-2-amine benzimidazoles as a new class of inhibitors of hepatitis B virus.鉴定1-异丙基磺酰基-2-胺基苯并咪唑为一类新型乙型肝炎病毒抑制剂。
Eur J Med Chem. 2007 Nov-Dec;42(11-12):1358-64. doi: 10.1016/j.ejmech.2007.03.005. Epub 2007 Mar 31.
6
[Design, synthesis and anti-hBV evaluation of adefovir mono-L-amino acid ester, mono non-steroidal anti-inflammatory drugs carboxylic ester prodrugs].阿德福韦单-L-氨基酸酯、单非甾体抗炎药羧酸酯前药的设计、合成及抗乙肝病毒评价
Yao Xue Xue Bao. 2010 Aug;45(8):1017-24.
7
[Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].[无环核苷膦酸酯L-氨基酸酯前药的设计、合成及抗乙肝病毒活性]
Yao Xue Xue Bao. 2008 May;43(5):495-503.
8
Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs.拓展3-氟-2-(膦酰甲氧基)丙基无环核苷膦酸酯的抗病毒谱:二戊基天冬氨酸酰胺前药
J Med Chem. 2017 Jul 27;60(14):6220-6238. doi: 10.1021/acs.jmedchem.7b00416. Epub 2017 Jul 6.
9
Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).抗病毒药物9-[2-(膦酰甲氧基)乙基]腺嘌呤(PMEA)前药的合成、口服生物利用度测定及体外评价
J Med Chem. 1994 Jun 10;37(12):1857-64. doi: 10.1021/jm00038a015.
10
Bisamidate Prodrugs of 2-Substituted 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis.2-取代的9-[2-(膦酰甲氧基)乙基]腺嘌呤(PMEA,阿德福韦)的双酰胺前药作为百日咳博德特氏菌腺苷酸环化酶毒素的选择性抑制剂
ChemMedChem. 2015 Aug;10(8):1351-64. doi: 10.1002/cmdc.201500183. Epub 2015 Jul 1.

引用本文的文献

1
Towards reproducible computational drug discovery.迈向可重复的计算药物发现。
J Cheminform. 2020 Jan 28;12(1):9. doi: 10.1186/s13321-020-0408-x.
2
AVCpred: an integrated web server for prediction and design of antiviral compounds.AVCpred:一个用于抗病毒化合物预测与设计的集成网络服务器。
Chem Biol Drug Des. 2017 Jan;89(1):74-83. doi: 10.1111/cbdd.12834. Epub 2016 Sep 9.

本文引用的文献

1
Identification of 1-isopropylsulfonyl-2-amine benzimidazoles as a new class of inhibitors of hepatitis B virus.鉴定1-异丙基磺酰基-2-胺基苯并咪唑为一类新型乙型肝炎病毒抑制剂。
Eur J Med Chem. 2007 Nov-Dec;42(11-12):1358-64. doi: 10.1016/j.ejmech.2007.03.005. Epub 2007 Mar 31.
2
Design and synthesis of novel bis(L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with improved anti-HBV activity.9-[2-(膦酰甲氧基)乙基]腺嘌呤(PMEA)新型双(L-氨基酸)酯前药的设计与合成及其抗乙肝病毒活性的提高
Bioorg Med Chem Lett. 2007 Jan 15;17(2):465-70. doi: 10.1016/j.bmcl.2006.10.021. Epub 2006 Oct 12.
3
New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.从肝内病毒cccDNA研究中获得的关于乙型肝炎病毒持续感染的新见解。
J Hepatol. 2005 Mar;42(3):302-8. doi: 10.1016/j.jhep.2004.12.015.
4
Current therapies for chronic hepatitis B virus infection.慢性乙型肝炎病毒感染的当前疗法。
Expert Rev Anti Infect Ther. 2004 Oct;2(5):745-60. doi: 10.1586/14789072.2.5.745.
5
Novel treatment options for hepatitis B virus infection.乙型肝炎病毒感染的新型治疗选择。
Curr Opin Investig Drugs. 2004 Feb;5(2):171-8.
6
Antiviral therapy for chronic hepatitis B: a review.慢性乙型肝炎的抗病毒治疗:综述
Curr Drug Targets Inflamm Allergy. 2004 Mar;3(1):63-70. doi: 10.2174/1568010043483908.
7
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.乙型肝炎病毒流行病学、疾病负担、治疗以及当前和新出现的预防控制措施。
J Viral Hepat. 2004 Mar;11(2):97-107. doi: 10.1046/j.1365-2893.2003.00487.x.
8
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.无环核苷膦酸酯西多福韦、阿德福韦和替诺福韦在治疗DNA病毒和逆转录病毒感染方面的临床潜力。
Clin Microbiol Rev. 2003 Oct;16(4):569-96. doi: 10.1128/CMR.16.4.569-596.2003.
9
Hepatitis B virus: old, new and future approaches to antiviral treatment.乙型肝炎病毒:抗病毒治疗的过去、现在与未来方法
J Antimicrob Chemother. 2003 Apr;51(4):761-85. doi: 10.1093/jac/dkg163. Epub 2003 Mar 13.
10
2-Amino-6-arylthio-9-[2-(phosphonomethoxy)ethyl]purine bis(2,2,2-trifluoroethyl) esters as novel HBV-specific antiviral reagents.2-氨基-6-芳硫基-9-[2-(膦酰甲氧基)乙基]嘌呤双(2,2,2-三氟乙基)酯作为新型乙肝病毒特异性抗病毒试剂。
J Med Chem. 2002 Jul 4;45(14):3138-42. doi: 10.1021/jm020036x.